Harnessing Analytical Development To Empower Process Development For Successful Manufacturing

In the pursuit of expedited drug development, a variety of molecules including monoclonal antibodies, multi-specific proteins, antibody fragments, and fusion proteins, are being developed on accelerated timelines for IND applications. This urgent need for high quality analytics highlights the critical requirement for rapid and reliable process development methodologies tailored to meet current demands.

In this webinar, we will discuss Samsung Biologics' strategy for analytical development and introduce case studies for their new offering, Host Cell Protein (HCP) identification, and Sequence Variant Analysis (SVA) by mass spectrometry.

Key Learning Objectives:

• Exploring Samsung Biologics' comprehensive analytical capabilities, which are tailored to the molecule type and mechanism of action.
• Understand the need for HCP identification in addition to HCP quantification.
• Analyzing case studies demonstrating the successful application of SVA to improve manufacturing processes.

View the webinar below and examine an approach to analytical development tailored to specific molecule types and their mechanisms of action.